Cited by — Long-term real-world effectiveness and safety of mirikizumab in ulcerative colitis: 52-Week results from an expanded international two-center retrospective cohort study | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Long-term real-world effectiveness and safety of mirikizumab in ulcerative colitis: 52-Week results from an expanded international two-center retrospective cohort study.
No admitted local citation edges point to this work yet.
